Travere Therapeutics Inc (TVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 84,772 | 62,436 | 102,873 | 99,394 | 41,002 |
| Marketable Securities | 276,817 | 336,088 | 368,668 | 201,236 | 214,871 |
| Receivables | 33,067 | 19,443 | 12,662 | 13,872 | 18,510 |
| Inventories | 7,608 | 6,082 | 5,619 | 5,351 | 2,826 |
| Other current assets | 0 | 0 | 0 | 0 | 46,849 |
| TOTAL | $410,407 | $429,064 | $495,678 | $325,807 | $332,352 |
| Non-Current Assets | |||||
| PPE Net | 9,418 | 2,891 | 3,146 | 3,230 | 2,587 |
| Investments And Advances | 0 | 0 | 15,000 | 0 | 0 |
| Intangibles | 154,125 | 158,136 | 187,627 | 185,753 | 182,979 |
| Other Non-Current Assets | 33,489 | 14,709 | 7,709 | 5,556 | 7,364 |
| TOTAL | $197,032 | $175,736 | $213,482 | $194,539 | $192,930 |
| Total Assets | $607,439 | $604,800 | $709,160 | $520,346 | $525,282 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 12,133 | 26,614 | 6,954 | 18,938 | 7,522 |
| Accrued Expenses | 56,793 | 51,745 | 49,695 | 36,018 | 33,308 |
| Other current liabilities | 23,377 | 17,090 | 25,515 | 30,712 | 42,432 |
| TOTAL | $92,660 | $95,449 | $104,621 | $85,668 | $83,262 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 303,566 | 288,155 | 286,286 | 141,544 | 127,828 |
| TOTAL | $303,566 | $288,155 | $286,286 | $141,544 | $134,253 |
| Total Liabilities | $396,226 | $383,604 | $390,907 | $227,212 | $217,515 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 60,236 | 43,116 | 41,413 | 39,693 | 38,094 |
| Common Shares | 5 | 4 | 4 | 4 | 4 |
| Retained earnings | -585,875 | -416,444 | -270,017 | -177,655 | -113,056 |
| Other shareholders' equity | -902 | 726 | -1,529 | -1,015 | -490 |
| TOTAL | $211,213 | $221,196 | $318,253 | $293,134 | $307,767 |
| Total Liabilities And Equity | $607,439 | $604,800 | $709,160 | $520,346 | $525,282 |